| Filed | Form | Description | |
|---|---|---|---|
| 10/15/24 | SC 13G/A | SC 13G/A | → |
| 2/14/24 | SC 13G | SCHEDULE FILED TO REPORT ACQUISITION OF BENEFICIAL OWNERSHIP | → |
| 2/11/22 | SC 13G/A | SC 13G/A | → |
| 2/9/22 | SC 13G/A | SC 13G/A | → |
| 2/16/21 | SC 13G/A | SC 13G/A | → |
| 2/12/21 | SC 13G/A | EVOGENE LTD. | → |
| ↓ | |||
Evogene is a computational chemistry company based in Israel, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries. At the core of its technology is ChemPass AI, a proprietary generative AI engine that enables the design of novel, highly potent small molecules optimized across multiple critical parameters.